^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    GIM-122

    i
    Other names: GIM-122
    Associations

    News

    Trials
    Company:
    Georgiamune
    Drug class:
    T-cell stimulant
    Related drugs:
    Associations

    News

    Trials
    10ms
    Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies (clinicaltrials.gov)
    P1/2, N=111, Recruiting, Georgiamune Inc | Not yet recruiting --> Recruiting
    Enrollment open
    |
    LAG3 (Lymphocyte Activating 3)
    |
    GIM-122
    1year
    Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies (clinicaltrials.gov)
    P1/2, N=111, Not yet recruiting, Georgiamune Inc
    New P1/2 trial • Metastases
    |
    LAG3 (Lymphocyte Activating 3)
    |
    GIM-122